Asian Spectator

Times Advertising

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Krisis ojol: Promo selalu mencekik pengemudi, jam-jam padat malah bikin rugi

● Masyarakat makin sering mengeluhkan langkanya ojol di waktu-waktu tertentu.● Padahal seharusnya upah yang didapat para ojol meningkat jika melihat meroketnya tarif yang dibebankan kepada...

Benarkah sering ejakulasi bisa kurangi risiko kanker prostat? Jawabannya tidak sesederhana itu

Kanker prostat menempati urutan kedua global sebagai jenis kanker paling banyak didiagnosis pada laki-laki, setelah kanker paru-paru. Di Inggris, kanker prostat merupakan kanker yang paling umum diala...

Jejak pengetahuan astronomi Nusantara sejak lebih dari 1000 tahun lalu: Dari candi hingga prasasti kuno

● Astronomi Indonesia telah berkembang sejak abad ke-7 dan ke-8 Masehi, jauh sebelum Observatorium Bosscha berdiri pada 1920.● Pendekatan astro-arkeologi mengungkap bahwa orientasi candi e...